| Heart disease and stroke statistics-2018 update: a report from the American Heart Association. EJ Benjamin, SS Virani, CW Callaway, AM Chamberlain, AR Chang, ... Circulation 137 (12), e67, 2018 | 2470 | 2018 |
| The genetic architecture of type 2 diabetes C Fuchsberger, J Flannick, TM Teslovich, A Mahajan, V Agarwala, ... Nature 536 (7614), 41, 2016 | 601 | 2016 |
| Loss-of-function mutations in SLC30A8 protect against type 2 diabetes J Flannick, G Thorleifsson, NL Beer, SBR Jacobs, N Grarup, NP Burtt, ... Nature genetics 46 (4), 357, 2014 | 333 | 2014 |
| Lower risk of heart failure and death in patients initiated on sodium-glucose cotransporter-2 inhibitors versus other glucose-lowering drugs: the CVD-REAL study (comparative … M Kosiborod, MA Cavender, AZ Fu, JP Wilding, K Khunti, RW Holl, ... Circulation 136 (3), 249-259, 2017 | 280 | 2017 |
| Rare and low-frequency coding variants alter human adult height E Marouli, M Graff, C Medina-Gomez, KS Lo, AR Wood, TR Kjaer, RS Fine, ... Nature 542 (7640), 186, 2017 | 274 | 2017 |
| Greenlandic Inuit show genetic signatures of diet and climate adaptation M Fumagalli, I Moltke, N Grarup, F Racimo, P Bjerregaard, ME Jørgensen, ... Science 349 (6254), 1343-1347, 2015 | 257 | 2015 |
| Rapid tachyphylaxis of the glucagon-like peptide 1–induced deceleration of gastric emptying in humans MA Nauck, G Kemmeries, JJ Holst, JJ Meier Diabetes 60 (5), 1561-1565, 2011 | 247 | 2011 |
| An expanded genome-wide association study of type 2 diabetes in Europeans RA Scott, LJ Scott, R Mägi, L Marullo, KJ Gaulton, M Kaakinen, ... Diabetes 66 (11), 2888-2902, 2017 | 245 | 2017 |
| Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci KJ Gaulton, T Ferreira, Y Lee, A Raimondo, R Mägi, ME Reschen, ... Nature genetics 47 (12), 1415, 2015 | 233 | 2015 |
| A common Greenlandic TBC1D4 variant confers muscle insulin resistance and type 2 diabetes I Moltke, N Grarup, ME Jørgensen, P Bjerregaard, JT Treebak, ... Nature 512 (7513), 190, 2014 | 226 | 2014 |
| Identification of low-frequency and rare sequence variants associated with elevated or reduced risk of type 2 diabetes V Steinthorsdottir, G Thorleifsson, P Sulem, H Helgason, N Grarup, ... Nature genetics 46 (3), 294, 2014 | 225 | 2014 |
| Moving to an A1C-based diagnosis of diabetes has a different impact on prevalence in different ethnic groups DL Christensen, DR Witte, L Kaduka, ME Jørgensen, K Borch-Johnsen, ... Diabetes care 33 (3), 580-582, 2010 | 187 | 2010 |
| Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs … KI Birkeland, ME Jørgensen, B Carstensen, F Persson, HL Gulseth, ... The Lancet Diabetes & Endocrinology 5 (9), 709-717, 2017 | 157 | 2017 |
| Exome-wide association study of plasma lipids in> 300,000 individuals DJ Liu, GM Peloso, H Yu, AS Butterworth, X Wang, A Mahajan, ... Nature genetics 49 (12), 1758, 2017 | 150 | 2017 |
| Diabetes and impaired glucose tolerance among the Inuit population of Greenland ME Jørgensen, P Bjeregaard, K Borch-Johnsen, V Backer, U Becker, ... Diabetes Care 25 (10), 1766-1771, 2002 | 147 | 2002 |
| Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps A Mahajan, D Taliun, M Thurner, NR Robertson, JM Torres, NW Rayner, ... Nature genetics 50 (11), 1505, 2018 | 146 | 2018 |
| Health transitions in Arctic populations TK Young University of Toronto Press, 2008 | 146 | 2008 |
| Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility J Wessel, AY Chu, SM Willems, S Wang, H Yaghootkar, JA Brody, ... Nature communications 6, 5897, 2015 | 133 | 2015 |
| Cardiovascular events associated with SGLT-2 inhibitors versus other glucose-lowering drugs: the CVD-REAL 2 study M Kosiborod, CSP Lam, S Kohsaka, DJ Kim, A Karasik, J Shaw, N Tangri, ... Journal of the American College of Cardiology 71 (23), 2628-2639, 2018 | 131 | 2018 |
| GLP-1 response to oral glucose is reduced in prediabetes, screen-detected type 2 diabetes, and obesity and influenced by sex: the ADDITION-PRO study K Færch, SS Torekov, D Vistisen, NB Johansen, DR Witte, A Jonsson, ... Diabetes 64 (7), 2513-2525, 2015 | 117 | 2015 |
